Clinical Trials Sponsored by Hangzhou Endonom Medtech Co., Ltd.

Total 542 results

The First Affiliated Hospital of Zhengzhou University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia

Tumor Therapy-related Thrombocytopenia
Zhou Chengzhi
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP

Malignant Tumor | Pneumonitis

China
The First Affiliated Hospital of Zhengzhou University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Squamous Cell Carcinoma
Lee's Pharmaceutical Limited
Powder (Guangzhou) Pharmaceuticals Limited; Powder Pharmaceuticals (HK) Co....

Not yet recruiting

A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes

Diabetes
The First Affiliated Hospital of Zhengzhou University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC

Locally Advanced Esophageal Squamous Cell Carcinoma

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.; BGI-Shenzhen

Completed

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma | Immunotherapy

China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
The First Affiliated Hospital of Zhengzhou University

Unknown

CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia | T-lymphoblastic Lymphoma | NK/T Cell Lymphoma

China
The First Affiliated Hospital of Zhengzhou University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC

Esophageal Squamous Cell Carcinoma

China
Second Affiliated Hospital, School of Medicine,...
Zhejiang University; Hangzhou yuansheng biotechnology Co., Ltd

Not yet recruiting

Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm

Dry Eye Disease

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Withdrawn

A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI

NSCLC

China
National Vaccine and Serum Institute, China
Beijing Institute of Biological Products Co Ltd.; Lanzhou Institute of Biological...

Active, not recruiting

Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

COVID-19 Pneumonia

China
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients

Neutropenia

China
The Affiliated Hospital of Xuzhou Medical University
Guangzhou Bioresette Biomedical Technology Co., Ltd.

Recruiting

BGT007 Cells for the Treatment of Refractory Digestive System Tumors

Gastrointestinal Cancer

China
Techpool Bio-Pharma Co., Ltd.
The First Affiliated Hospital of Guangzhou Medical University

Unknown

The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)

Acute Respiratory Distress Syndrome

China
First Affiliated Hospital of Jinan University
Science and Technology Program of Guangzhou,Guangzhou Sipintang Biological...

Unknown

The Combination Therapy of Nanofat Grafting and PRP Compared With Microfat Grafting and PRP Synergy in Treating Striae Distensae

Treatments of Striae Distensae

China
The Affiliated Hospital of Xuzhou Medical University
Guangzhou Bioresette Biomedical Technology Co., Ltd.

Recruiting

BGT007H Cells for the Treatment of Refractory Digestive System Tumors

Digestive Tract Cancer

China
Second Affiliated Hospital of Guangzhou Medical...
Guangdong Zhaotai InVivo Biomedicine Co. Ltd.

Recruiting

Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors

Hepatocellular Carcinoma | Lung Cancer | Solid Tumor

China
Second Affiliated Hospital of Guangzhou Medical...
Guangdong Zhaotai InVivo Biomedicine Co. Ltd.

Recruiting

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Breast Cancer | Lung Cancer | Brain Tumor | Colo-rectal Cancer | Liver Cancer | Solid Tumor, Adult | CTLA4 | PD1

China
The First Affiliated Hospital of Zhengzhou University
Yichang Humanwell Pharmaceutical Co., Ltd., China

Unknown

the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation

Critical Illness
The Affiliated Hospital of Xuzhou Medical University
Guangzhou Bioresette Biomedical Technology Co., Ltd.

Recruiting

EBV CAR-T Cells for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
The Affiliated Hospital of Xuzhou Medical University
Guangzhou Bioresette Biomedical Technology Co., Ltd.

Recruiting

BGT007 Cell Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou Medical University; IIT MediTech (Jiangsu) Co. Ltd

Recruiting

Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Ovarian Cancer

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
Second Affiliated Hospital, School of Medicine,...
Guangzhou Burning Rock Dx Co., Ltd.; Guangdong Living Environment Harmless...

Recruiting

Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods

Colorectal Cancer Metastatic

China
National Vaccine and Serum Institute, China
Lanzhou Institute of Biological Products Co., Ltd

Not yet recruiting

Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)

Norwalk Gastroenteritis | Norovirus Infections
Lanzhou Institute of Biological Products Co., Ltd
Air Force Military Medical University, China

Unknown

A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine

Meningococcal Meningitis

China
Guangzhou Recomgen Biotech Co., Ltd.
Peking University; Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI

Acute ST Elevation Myocardial Infarction

China
Second Affiliated Hospital, School of Medicine,...
Guangzhou Burning Rock Dx Co., Ltd.

Recruiting

Early-stage Detection of LIver, Biliary tRAct and pancReatic Cancers

Pancreatic Cancer | Liver Cancer | Biliary Tract Cancer

China
Qiu Lugui
Guangzhou Burning Rock Dx Co., Ltd.

Recruiting

Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma

Multiple Myeloma

China
Second Affiliated Hospital of Guangzhou Medical...
Hunan Zhaotai Yongren Medical Innovation Co. Ltd.

Recruiting

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Anti-cancer Cell Immunotherapy | T Cell and NK Cell

China
Liang Peng
Guangzhou Virotech Pharmaceutical Co., Ltd.

Unknown

IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Advanced/Metastatic Hepatocellular Carcinoma
Fudan University
Guangzhou Bioresette Biomedical Technology Co., Ltd.; Chaosu Hu，Principal Investigator...

Recruiting

Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
The First Affiliated Hospital of Guangdong Pharmaceutical...
Guangzhou Anjie Biomedical Technology Co., Ltd.

Unknown

CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer

Advanced Esophageal Cancer

China
Beijing Friendship Hospital
Beijing Ditan Hospital; Nanfang Hospital of Southern Medical University; Ruijin... and other collaborators

Active, not recruiting

Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

Chronic Hepatitis b

China
Peking University People's Hospital
Guangzhou Burning Rock Medical Examination Institute Co., Ltd.; Beijing CSCO-Allist... and other collaborators

Not yet recruiting

ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas

Adenocarcinoma of Lung

China
Guangdong 999 Brain Hospital
Jinan University Guangzhou; Beijing Tricision Biotherapeutics Inc; Trinomab Biotech...

Completed

Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2) (PerCellVac2)

Glioblastoma

China
Shenzhen Zhongxing Yangfan Biotech Co. Ltd.
The 12th Guangzhou Municipal Hospital; Liu Hua Qiao Hospital

Unknown

Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia

Anemia, Aplastic

China
Cancer Institute and Hospital, Chinese Academy...
Guangzhou Burning Rock Dx Co., Ltd.

Recruiting

A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy (PROMISE)

Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Guangzhou Burning Rock Dx Co., Ltd.

Recruiting

Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT (PRESCIENT)

Cancer

China
Guangdong 999 Brain Hospital
Jinan University Guangzhou; Beijing Tricision Biotherapeutics Inc; Trinomab Biotech...

Completed

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) (PerCellVac3)

Brain Cancer | Neoplasm Metastases

China
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd...
The First Affiliated Hospital of Guangzhou Medical University

Not yet recruiting

Study of Human Bone Marrow Mesenchymal Stem Cells in aPAP

Autoimmune Pulmonary Alveolar Proteinosis
Guangdong 999 Brain Hospital
Jinan University Guangzhou; Beijing Tricision Biotherapeutics Inc; Trinomab Biotech...

Completed

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) (PERCELLVAC)

Glioblastoma

China
Wanbangde Pharmaceutical Group Co., LTD
The First Affiliated Hospital, Guangzhou University of Traditional Chinese...

Unknown

The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression

Stable Angina Pectoris Associated With Depression

China
Jiangsu Province Centers for Disease Control and...
Lanzhou Institute of Biological Products Co., Ltd

Completed

Immunogenicity and Safety of Subunit Plague Vaccine

Plague

China
Peking University Third Hospital
Merck Serono GmbH, Germany; Fountain Medical Development Co., Ltd.; Guangzhou...

Unknown

To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment (CLBR)

Sterility

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou Anjie Biomedical Technology Co., Ltd.

Completed

PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer

Advanced Breast Cancer | Breast Neoplasm Malignant Female

China
Second Affiliated Hospital, School of Medicine,...
Guangzhou Burning Rock Medical Examination Institute Co., Ltd.

Completed

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer

Lynch Syndrome

China
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

COVID-19

United Arab Emirates
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Lanzhou Institute of Biological... and other collaborators

Recruiting

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Coronavirus Infections | COVID-19 Pneumonia

United Arab Emirates
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Coronavirus Infections | COVID-19

United Arab Emirates

Clinical Trials Sponsored by Hangzhou Endonom Medtech Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations